What's breaking now, across thousands of outlets.
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
Key PointsVanEck Pharmaceutical ETF offers a lower-volatility profile and a higher 1.9% dividend yield compared to State Street SPDR S&P Biotech ETF.
These funds give investors exposure to top oil and gas and utility stocks, while paying above-average dividends.
Berkshire Hathaway has built a nearly $38 billion Alphabet stake from scratch in under a year. It seems likely Warren Buffett is spearheading the investment.
This oft-overlooked cryptocurrency still has a bright future.
On Thursday, July 9, S&P cut Oracle's issuer credit rating from BBB to BBB- . That's one step above junk, which, for a company as old and big and staid as Oracle, is ... not good.
